6-(7-Methoxy-9H-thioxanthen-4-yl)-1-methyl-4-morpholino-pyridin-2-one

ID: ALA4872413

PubChem CID: 164622518

Max Phase: Preclinical

Molecular Formula: C24H24N2O3S

Molecular Weight: 420.53

Molecule Type: Unknown

Names and Identifiers

Canonical SMILES:  COc1ccc2c(c1)Cc1cccc(-c3cc(N4CCOCC4)cc(=O)n3C)c1S2

Standard InChI:  InChI=1S/C24H24N2O3S/c1-25-21(14-18(15-23(25)27)26-8-10-29-11-9-26)20-5-3-4-16-12-17-13-19(28-2)6-7-22(17)30-24(16)20/h3-7,13-15H,8-12H2,1-2H3

Standard InChI Key:  RMKVYOXYSCXKMS-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 30 34  0  0  0  0  0  0  0  0999 V2000
   20.8136   -1.3496    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   20.8136   -2.1709    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5230   -2.5795    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.2324   -2.1709    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.2324   -1.3496    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5230   -0.9369    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9432   -2.5835    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9401   -3.4058    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6431   -3.8153    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3580   -3.4113    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.3611   -2.5890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6494   -2.1708    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0727   -2.1824    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.5006   -1.3695    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.7857   -0.9576    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0753   -1.3644    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.4961   -2.1916    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.7790   -2.6024    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.7746   -3.4229    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   27.2090   -2.6054    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.2030   -3.4321    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.4858   -3.8342    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.4785   -4.6551    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.1877   -5.0748    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.9057   -4.6635    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.9094   -3.8440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.6114   -5.0797    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   28.6074   -5.9010    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6378   -4.6325    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   25.0630   -3.8244    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  6  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  7  8  2  0
  7 12  1  0
  8  9  1  0
  9 10  1  0
 10 11  1  0
 11 12  2  0
  4  7  1  0
 13 18  2  0
 17 14  2  0
 14 15  1  0
 15 16  2  0
 16 13  1  0
 11 13  1  0
 17 18  1  0
 17 20  1  0
 18 19  1  0
 19 22  1  0
 21 20  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 21  1  0
 25 27  1  0
 27 28  1  0
  9 29  2  0
 10 30  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA4872413

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 420.53

Molecular Weight (Monoisotopic): 420.1508

AlogP: 3.95

#Rotatable Bonds: 3

Polar Surface Area: 43.70

Molecular Species: NEUTRAL

HBA: 6

HBD: ┄

#RO5 Violations: ┄

HBA (Lipinski): 5

HBD (Lipinski): ┄

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: ┄

CX Basic pKa: ┄

CX LogP: 3.25

CX LogD: 3.25

Aromatic Rings: 3

Heavy Atoms: 30

QED Weighted: 0.50

Np Likeness Score: -0.78

References

1. Van de Poël A, Toledo-Sherman L, Breccia P, Cachope R, Bate JR, Angulo-Herrera I, Wishart G, Matthews KL, Martin SL, Peacock M, Barnard A, Cox HC, Jones G, McAllister G, Vater H, Esmieu W, Clissold C, Lamers M, Leonard P, Jarvis RE, Blackaby W, Eznarriaga M, Lazari O, Yates D, Rose M, Jang SW, Muñoz-Sanjuan I, Dominguez C..  (2021)  Structure-Based Exploration of Selectivity for ATM Inhibitors in Huntington's Disease.,  64  (8.0): [PMID:33783225] [10.1021/acs.jmedchem.1c00114]

Source

Source(1):

• Scientific Literature